Literature DB >> 32483657

Formulation and Delivery Technologies for mRNA Vaccines.

Chunxi Zeng1, Chengxiang Zhang1, Patrick G Walker2, Yizhou Dong3,4,5,6,7.   

Abstract

mRNA vaccines have become a versatile technology for the prevention of infectious diseases and the treatment of cancers. In the vaccination process, mRNA formulation and delivery strategies facilitate effective expression and presentation of antigens, and immune stimulation. mRNA vaccines have been delivered in various formats: encapsulation by delivery carriers, such as lipid nanoparticles, polymers, peptides, free mRNA in solution, and ex vivo through dendritic cells. Appropriate delivery materials and formulation methods often boost the vaccine efficacy which is also influenced by the selection of a proper administration route. Co-delivery of multiple mRNAs enables synergistic effects and further enhances immunity in some cases. In this chapter, we overview the recent progress and existing challenges in the formulation and delivery technologies of mRNA vaccines with perspectives for future development.

Entities:  

Year:  2020        PMID: 32483657      PMCID: PMC8195316          DOI: 10.1007/82_2020_217

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  233 in total

Review 1.  Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms.

Authors:  Matthias G von Herrath; Adrian Bot
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

2.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

3.  The 'anti-hype' vaccine.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

4.  Developing Covid-19 Vaccines at Pandemic Speed.

Authors:  Nicole Lurie; Melanie Saville; Richard Hatchett; Jane Halton
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

5.  mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells.

Authors:  Marie-Luce De Temmerman; Heleen Dewitte; Roosmarijn E Vandenbroucke; Bart Lucas; Claude Libert; Jo Demeester; Stefaan C De Smedt; Ine Lentacker; Joanna Rejman
Journal:  Biomaterials       Date:  2011-08-25       Impact factor: 12.479

6.  Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets.

Authors:  Anthony Conway; Matthew Mendel; Kenneth Kim; Kyle McGovern; Alisa Boyko; Lei Zhang; Jeffrey C Miller; Russell C DeKelver; David E Paschon; Barbara L Mui; Paulo J C Lin; Ying K Tam; Chris Barbosa; Tom Redelmeier; Michael C Holmes; Gary Lee
Journal:  Mol Ther       Date:  2019-03-07       Impact factor: 11.454

7.  Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.

Authors:  Shinu John; Olga Yuzhakov; Angela Woods; Jessica Deterling; Kimberly Hassett; Christine A Shaw; Giuseppe Ciaramella
Journal:  Vaccine       Date:  2018-02-15       Impact factor: 3.641

8.  Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.

Authors:  Margaret M Billingsley; Nathan Singh; Pranali Ravikumar; Rui Zhang; Carl H June; Michael J Mitchell
Journal:  Nano Lett       Date:  2020-02-05       Impact factor: 11.189

9.  Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

Authors:  D Boczkowski; S K Nair; D Snyder; E Gilboa
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.

Authors:  Claude Roth; Tineke Cantaert; Chloé Colas; Matthieu Prot; Isabelle Casadémont; Laurine Levillayer; Jessie Thalmensi; Pierre Langlade-Demoyen; Christiane Gerke; Kapil Bahl; Giuseppe Ciaramella; Etienne Simon-Loriere; Anavaj Sakuntabhai
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

View more
  44 in total

Review 1.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

2.  Optimization of Lipid Nanoformulations for Effective mRNA Delivery.

Authors:  Dekui Zhang; TiYun Han; Huiling Chen; Xuan Ren; Shi Xu
Journal:  Int J Nanomedicine       Date:  2022-07-02

Review 3.  mRNA-Based Vaccines.

Authors:  Frank Kowalzik; Daniel Schreiner; Christian Jensen; Daniel Teschner; Stephan Gehring; Fred Zepp
Journal:  Vaccines (Basel)       Date:  2021-04-15

Review 4.  mRNA vaccines manufacturing: Challenges and bottlenecks.

Authors:  Sara Sousa Rosa; Duarte M F Prazeres; Ana M Azevedo; Marco P C Marques
Journal:  Vaccine       Date:  2021-03-24       Impact factor: 4.169

Review 5.  Advances of nanomaterials-based strategies for fighting against COVID-19.

Authors:  Chunxi Zeng; Xucheng Hou; Margaret Bohmer; Yizhou Dong
Journal:  View (Beijing)       Date:  2021-05-05

Review 6.  Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.

Authors:  Ehsan Raoufi; Bahar Bahramimeimandi; M Salehi-Shadkami; Patcharida Chaosri; M R Mozafari
Journal:  Biomedicines       Date:  2021-05-06

Review 7.  Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

Authors:  Rossella Talotta; Erle S Robertson
Journal:  Cytokine Growth Factor Rev       Date:  2021-05-28       Impact factor: 7.638

Review 8.  From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 9.  Nano-Microparticle Platforms in Developing Next-Generation Vaccines.

Authors:  Giuseppe Cappellano; Hugo Abreu; Chiara Casale; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Vaccines (Basel)       Date:  2021-06-05

10.  Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.

Authors:  Nimrod Rahamimov; Veronica Baturov; Adi Shani; Ilai Ben Zoor; Doron Fischer; Anna Chernihovsky
Journal:  Vaccine       Date:  2021-07-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.